Please wait a minute...
医药导报  2019, Vol. 38 Issue (6): 807-810    DOI: 10.3870/j.issn.1004-0781.2019.06.028
  本期目录 | 过刊浏览 | 高级检索 |
替加环素不良反应分析
周峰(),吴小燕,郭晓辉()
解放军总医院海南分院药剂科,三亚 572013
全文: PDF(1121 KB)   HTML
输出: BibTeX | EndNote (RIS)      
摘要 

目的 探索替加环素不良反应发生规律,促进替加环素临床合理应用。方法 检索国内外有关替加环素不良反应文献报道,整理分析相关信息。结果 共检索到文献报道38例,患者多为高龄,不良反应主要是导致胰腺炎。结论 单用替加环素更易发生不良反应,应用过程中要着重预防胰腺炎的发生。

服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
周峰
吴小燕
郭晓辉
关键词 替加环素不良反应药品胰腺炎    
收稿日期: 2018-04-16      出版日期: 2019-06-11
引用本文:   
周峰,吴小燕,郭晓辉. 替加环素不良反应分析[J]. 医药导报, 2019, 38(6): 807-810.
链接本文:  
http://www.yydbzz.com/CN/Y2019/V38/I6/807
[1] BOUCHER H W,WENNERSTEN C B,ELIOPOULOS G M.In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria[J].Antimicrob Agents Chemother,2000,44(8):2225-2229.
doi: 10.1128/AAC.44.8.2225-2229.2000
[2] EDLUND C,NORD C E.In vitro susceptibility of anaerobic bacteria to GAR-936,a new glycylcycline[J].Clin Microbiol Infect,2000,6(3):159-163.
doi: 10.1046/j.1469-0691.2000.00034-6.x
[3] PANKEY G A.Tigecycline[J].J Antimicrob Chemother,2005,56(3):470-480.
doi: 10.1093/jac/dki248
[4] 陈佰义,何礼贤,胡必杰,等.中国鲍曼不动杆菌感染诊治与防控专家共识[J].中华医学杂志,2012,92(2):76-85.
[5] 梁慧,彭国钧,张薇,等.米诺环素、替加环素对多重耐药菌的体外抗菌活性比较[J].中国感染与化疗杂志,2012,12(5):390-392.
[6] DA SILVA L M,NUNES SALGADO H R.Tigecycline:a review of properties,applications,and analytical methods[J].Ther Drug Monit,2010,32(3) :282-288.
doi: 10.1097/FTD.0b013e3181dda54f
[7] BRINK A J,BIZOS D,BOFFARD K D,et al.Guideline summary:appropriate use of tigecycline[J].S Afri J Surg,2012,50(1):20-21.
[8] 张红翠,王晓伟,朱曼.1例替加环素超说明书用药致血小板降低的案例分析[J].中国药物应用与监测,2016,13(2):125-127.
[9] 陆永珍,田新君,杨敏,等.1例替加环素致反复发生低血糖的护理体会[J].当代护士(上旬刊),2017,(12):163-164.
[10] 吴健标,张春红.4例替加环素致肝功能衰竭的临床分析[J].中国生化药物杂志,2017,37(8):372-373.
[11] 肖昌钱,韩奇.替加环素致血小板减少2例[J].医药导报,2018,37(1):125-127.
[12] 杜春辉,赵艳玲,赵庆国.注射用替加环素致罕见急性胰腺炎1例[J].中国医院用药评价与分析,2017,17(10):1311-1312.
[13] 吴冰,陈世耀.替加环素致肌酐水平升高1例[J].中国药物应用与监测,2014,11(4):253-254.
[14] 杨焕芝,宋沧桑,李兴德,等.替加环素致全血细胞减少不良反应1例[J].中国医院药学杂志,2015,35(3):277-278.
[15] 裴素娟. 替加环素致顽固性低血糖1例[J].中国药师,2016,19(8):1561-1562.
[16] 张晋萍. 替加环素致严重腹泻1例[J].药物流行病学杂志,2011,20(12):660-661.
[17] 孙薇,文仲光.替加环素致重症药疹1例[J].临床肺科杂志,2015,20(1):187-188.
[18] 钟斌,彭芳,杨人泽.疑似替加环素致皮疹及严重凝血功能障碍1例[J].中国医院药学杂志,2016,36(18):1620.
doi: 10.13286/j.cnki.chinhosppharmacyj.2016.18.22
[19] 李远. 替加环素致急性胰腺炎1例[J].医药导报,2018,37(2):263-264.
[20] GILSON M,MOACHON L,JEANNE L,et al.Acute pancr-eatitis related to tigecycline:case report and review of the literature[J].Scand J Infect Dis,2008,40(8):681-683.
doi: 10.1080/00365540801938949
[21] SHAO Q Q,QIN L,RUAN G R,et al.Tigecycline-induced drug fever and leukemoid reaction:a case report[J].Medicine,2015,94(45):e1869.
doi: 10.1097/MD.0000000000001869
[22] SABANIS N,PASCHOU E,GAVRIILAKI E,et al.Hypo-fibrinogenemia induced by tigecycline:a potentially life-threatening coagulation disorder[J].Infect Dis,2015,47(10):743-746.
doi: 10.3109/23744235.2015.1043942
[23] HUNG W Y,KOGELMAN L,VOLPE G,et al.Tigecycline- induced acute pancreatitis:case report and literature review[J].Int J Antimicrob Agents,2009,34(5):486-489.
doi: 10.1016/j.ijantimicag.2009.05.004
[24] MCMAHAN J,MOENSTER R P.Tigecycline-induced coagulopathy[J].Am J Health Syst Pharm,2017,74(3):130-134.
doi: 10.2146/ajhp150894
[25] MILLS R D,WHITEHOUSE F.Hypoglycemia due to tigecycline therapy for a non-healing foot wound[J].Endocrine Rev,2014,35(Suppl):3.
doi: 10.1210/er.2014.35.issue-6.toc
[26] KANT R,CHANDRASEKARAN S,MUNIR K M,et al.Tigecycline-induced severe hypoglycemia in a patient with type 1 diabetes[J].Endocrine Reviews,2013,34(Suppl 3):1.
doi: 10.1210/er.2011-1057
[27] SHAH B,KAUSHIK S.Tigecyline induced hypoglycemia:a case report[J].Res J Pharm Biol Chem Sci,2014,5(4):1021-1023.
[28] MESA C D,DAJOYAG-MEJIA M A,ISSAC R,et al.Tigecycline-induced acute pancreatitis with rechallenge:a case report[J].J Pharm Technol,2013,29(1):3-8.
doi: 10.1177/875512251302900102
[29] WU P C,WU C C.Tigecycline-associated hypofibrinogene-mia:a case report and review of the literature[J].IDCases,2018,11:56-57.
doi: 10.1016/j.idcr.2018.01.003
[30] WU X,ZHAO P,DONG L,et al.A case report of patient with severe acute cholangitis with tigecycline treatment causing coagulopathy and hyprofibrinogenemia[J].Medicine,2017,96(49):e9124.
doi: 10.1097/MD.0000000000009124
[31] GIRYES S,AZZAM Z S,ISMAEL-BADARNEH R,et al.Severe coagulation disorder and thrombocytopenia associated with tigecycline-case report and review of literature[J].Curr Drug Saf,2017,12(1):7-9.
doi: 10.2174/1574886311666160920090714
[32] HEMPHILL M T,JONES K R.Tigecycline-induced acute pancreatitis in a cystic fibrosis patient:a case report and literature review[J].J Cyst Fibros,2016,15(1):e9-e11.
doi: 10.1016/j.jcf.2015.07.008
[33] MARSHALL S R.Tigecycline-induced pancreatitis[J].Hospital Pharm,2009,44(3):239-241.
doi: 10.1310/hpj4403-239
[34] PROT-LABARTHE S,YOUDAREN R,BENKERROU M,et al.Pediatric acute pancreatitis related to tigecycline[J].Pediatri Infect Dis J,2010,29(9):890-891.
[35] MAROT J C,JONCKHEERE S,MUNYENTWALI H,et al.Tigecycline- induced acute pancreatitis:about two cases and review of the literature[J].Acta Clin Belg,2012,67(3):229-232.
[36] PIERINGER H,SCHMEKAL B,BIESENBACH G,et al.Severe coagulation disorder with hypo-fibrinogenemia associated with the use of tigecycline[J].Ann Hematol,2010,89(10):1063-1064.
doi: 10.1007/s00277-010-0911-7
[37] ROSSITTO G,PIANO S,ROSI S,et al.Life-threatening coagulopathy and hypofibrinogenaemia induced by tigecycline in a patient with advanced liver cirrhosis[J].Eur J Gastroenterol Hepatol,2014,26(6):681-684.
[38] VANDECASTEELE S J,DE CEULAER J,WITTOUCK E.Tigecycline induced hyperpigmentation of the skin[J].Open Forum Infect Dis,2016,3(1):33.
[39] YILMAZ DURAN F,YLDRM H,SEN E M.A lesser known side effect of tigecycline:hypofibrinogenemia[J].Turk J Hematol,2018,35(1):83-84.
doi: 10.4274/tjh
[40] KADOYAMA K,SAKAEDA T,TAMON A,et al.Adverse event profile of tigecycline:data mining of the public version of the U.S.Food and Drug Administration adverse event reporting system[J].Biol Pharm Bull,2012,35(6):967-970.
doi: 10.1248/bpb.35.967
[41] OKON E,ENGELL C,VAN MANEN R,et al.Tigecycline-related pancreatitis:a review of spontaneous adverse event reports[J].Pharmacotherapy,2013,33(1):63-68.
doi: 10.1002/phar.1159
[42] ZHANG Q,ZHOU S,ZHOU J.Tigecycline treatment causes a decrease in fibrinogen levels[J].Antimicrob Agents Chemother,2015,59(3):1650-1655.
doi: 10.1128/AAC.04305-14 pmid: 25547356
[43] LIPSHITZ J,KRUH J,CHEUNG P,et al.Tigecycline-induced pancreatitis[J].J Clin Gastroenterol,2009,43(1):93.
[44] 《上海医药》编辑部.FDA警告辉瑞旗下替加环素增加患者的死亡风险[J].上海医药,2013,34(19):61-62.
[1] 赵德华,楚明明,陈静,贾霖,韩建军,何霞,龙小庆,王继生. 食物对小分子靶向药物生物利用度的影响[J]. 医药导报, 2019, 38(6): 796-799.
[2] 罗利雄,汪延安,卢童. 某院用药指导单的设计与效果*[J]. 医药导报, 2019, 38(6): 826-828.
[3] 牛瑞,向玉芳,张智,赵楠,苟喜兰,冯变玲. 药品不良反应报告质量评估体系的建立*[J]. 医药导报, 2019, 38(6): 815-819.
[4] 祝晓雨,张伟光,孙树森,赵志刚. 中国药物警戒的发展及文献计量分析*[J]. 医药导报, 2019, 38(6): 820-825.
[5] 吴泊,谢诚. 尼可地尔联合抗血栓治疗触发脑出血1例[J]. 医药导报, 2019, 38(6): 811-812.
[6] 朱建成,吕光辉,阮平平,陈黎. 注射用盐酸多西环素致全身性水泡1例[J]. 医药导报, 2019, 38(6): 813-814.
[7] 肖婷婷,肖永红. 替加环素临床应用剖析*[J]. 医药导报, 2019, 38(5): 544-550.
[8] 赵晓燕,辛海莉. 盐酸莫西沙星氯化钠注射液致视幻觉1例[J]. 医药导报, 2019, 38(5): 667-668.
[9] 孔燕,焦鲁青,孙成春,杨平. 药学干预对规范医院临床科室麻醉药品管理的效果[J]. 医药导报, 2019, 38(5): 676-679.
[10] 吴健标,张春红. 多重耐药菌致颅内感染患者的药学监护[J]. 医药导报, 2019, 38(5): 659-662.
[11] 朱玉梅. 右美托咪定联合达克罗宁胶浆预防鼻内镜手术患者全身麻醉苏醒期躁动30例[J]. 医药导报, 2019, 38(5): 599-602.
[12] 王宇,饶友义,宁红,寇国先,杨勇. 索非布韦神经精神不良反应的信号挖掘[J]. 医药导报, 2019, 38(5): 663-667.
[13] 葛丽娟,孙美玲. 注射用核糖核酸Ⅱ致过敏性休克1例[J]. 医药导报, 2019, 38(3): 402-402.
[14] 刘培培,冯赵慧子. 利奈唑胺注射液致视物模糊1例[J]. 医药导报, 2019, 38(3): 400-401.
[15] 何江,陈红芳,何荣连. 强力枇杷露致皮肤变态反应1例[J]. 医药导报, 2019, 38(2): 267-267.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   

通信地址:武汉市蔡甸区中法生态城同济医院专家社区C栋平层《医药导报》编辑部,邮政编码:430199
鄂ICP备07004419号
版权所有:《医药导报》编辑部
网址:www.yydb.cn;www.yydbzz.com
电话:027-69378382,69378383 电子邮箱: yydbzz@163.com
技术支持:北京玛格泰克科技发展有限公司 鄂ICP备09001709号-11